spevigo
boehringer ingelheim international gmbh - spesolimab - psoriasis - immunosuppressantit - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.
spesimax 23.75 mg depottabletti
oy leiras finland ab - metoprololi succinas - depottabletti - 23.75 mg - metoprololi
spesimax 47.5 mg depottabletti
oy leiras finland ab - metoprololi succinas - depottabletti - 47.5 mg - metoprololi
spesimax 190 mg depottabletti
oy leiras finland ab - metoprololi succinas - depottabletti - 190 mg - metoprololi
spesimax 95 mg depottabletti
oy leiras finland ab - metoprololi succinas - depottabletti - 95 mg - metoprololi